BeOne Medicines (BEIGF) Prepaid Assets (2015 - 2026)
BeOne Medicines' (BEIGF) quarterly Prepaid Assets came in at $329.0 million in Q2 2026, up 17.28% year-over-year from $280.5 million in Q2 2025, and up 73.15% quarter-over-quarter from $190.0 million in Q1 2026.
Analysis
BeOne Medicines (BEIGF) Prepaid Assets (2015 - 2026) Analysis & Trends
BeOne Medicines (BEIGF) has reported Prepaid Assets for 12 consecutive years, with $329.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Prepaid Assets rose 17.28% year-over-year to $329.0 million in Q2 2026; TTM through Jun 2026 was $329.0 million, a 17.28% increase from a year earlier, with the FY2025 full-year figure at $212.8 million, up 10.28% from the prior year.
- Prepaid Assets was $329.0 million for Q2 2026 at BeOne Medicines, up from $190.0 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $329.0 million in Q2 2026 and troughed at $168.2 million in Q1 2025.
- A 5-year average of $235.0 million and a median of $232.2 million in 2024 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets soared 55.45% in 2022 and dropped 27.43% in 2025, its largest moves.
- Over 5 years, Prepaid Assets stood at $216.6 million in 2022, then increased by 18.89% to $257.5 million in 2023, then retreated by 25.07% to $192.9 million in 2024, then grew by 10.28% to $212.8 million in 2025, then soared by 54.63% to $329.0 million in 2026.
- The last three Prepaid Assets figures came in at $329.0 million (Q2 2026), $190.0 million (Q1 2026), and $212.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.95 Bn | 625.20 Bn | 17.26 Bn |
| 2 | AbbVie | 441.39 Bn | 434.82 Bn | 12.70 Bn |
| 3 | Merck | 366.72 Bn | 359.58 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.68 Bn | 258.99 Bn | 11.24 Bn |
| 5 | Pfizer | 159.20 Bn | 147.50 Bn | 10.94 Bn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - |
| 8 | Incyte | 25.50 Bn | 20.96 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.54 Bn | 18.88 Bn | 683.80 Mn |
| 10 | BeOne Medicines | 2.48 Bn | -2.62 Bn | 1.53 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 328.98 Mn |
| Mar 31, 2026 | 190.00 Mn |
| Dec 31, 2025 | 212.75 Mn |
| Sep 30, 2025 | 232.64 Mn |
| Jun 30, 2025 | 280.52 Mn |
| Mar 31, 2025 | 168.18 Mn |
| Dec 31, 2024 | 192.92 Mn |
| Sep 30, 2024 | 209.08 Mn |
| Jun 30, 2024 | 273.66 Mn |
| Mar 31, 2024 | 231.74 Mn |
| Dec 31, 2023 | 257.47 Mn |
| Sep 30, 2023 | 241.66 Mn |
| Jun 30, 2023 | 255.05 Mn |
| Mar 31, 2023 | 264.84 Mn |
| Dec 31, 2022 | 216.55 Mn |
| Sep 30, 2022 | 199.77 Mn |
| Jun 30, 2022 | 207.38 Mn |
| Mar 31, 2022 | 266.44 Mn |
| Dec 31, 2021 | 270.17 Mn |
| Sep 30, 2021 | 235.02 Mn |